A, H., EC, B., AC, R., JE, R., AS, M., DJ, D., . . . GA, A. (2025). Barriers and facilitators to representative acute leukemia trial participation at National Cancer Institute-designated comprehensive cancer centers. The oncologist, 30(9), . https://doi.org/10.1093/oncolo/oyaf241
Chicago Style (17th ed.) CitationA, Hantel, Blackstone EC, Revette AC, Roberts JE, Mims AS, DeAngelo DJ, Lathan CS, and Abel GA. "Barriers and Facilitators to Representative Acute Leukemia Trial Participation at National Cancer Institute-designated Comprehensive Cancer Centers." The Oncologist 30, no. 9 (2025). https://doi.org/10.1093/oncolo/oyaf241.
MLA (9th ed.) CitationA, Hantel, et al. "Barriers and Facilitators to Representative Acute Leukemia Trial Participation at National Cancer Institute-designated Comprehensive Cancer Centers." The Oncologist, vol. 30, no. 9, 2025, https://doi.org/10.1093/oncolo/oyaf241.